114 related articles for article (PubMed ID: 29807632)
1. Trends in the clinical presentation, treatment, and survival for pancreatic adenocarcinoma.
Salami A; Obaid T; Joshi ART
Am J Surg; 2019 Jan; 217(1):103-107. PubMed ID: 29807632
[TBL] [Abstract][Full Text] [Related]
2. Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.
Shapiro M; Chen Q; Huang Q; Boosalis VA; Yoon CH; Saund MS; Whang EE; Gold JS
JAMA Surg; 2016 Apr; 151(4):338-45. PubMed ID: 26581025
[TBL] [Abstract][Full Text] [Related]
3. Improvement in treatment and outcome of pancreatic ductal adenocarcinoma in north China.
Chen Y; Hao J; Ma W; Tang Y; Gao C; Hao X
J Gastrointest Surg; 2011 Jun; 15(6):1026-34. PubMed ID: 21484493
[TBL] [Abstract][Full Text] [Related]
4. Implications of inaccurate clinical nodal staging in pancreatic adenocarcinoma.
Swords DS; Firpo MA; Johnson KM; Boucher KM; Scaife CL; Mulvihill SJ
Surgery; 2017 Jul; 162(1):104-111. PubMed ID: 28238344
[TBL] [Abstract][Full Text] [Related]
5. Preoperative endoscopic ultrasound-guided fine needle aspiration does not impair survival of patients with resected pancreatic cancer.
Ngamruengphong S; Swanson KM; Shah ND; Wallace MB
Gut; 2015 Jul; 64(7):1105-10. PubMed ID: 25575893
[TBL] [Abstract][Full Text] [Related]
6. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma.
Kantor O; Talamonti MS; Lutfi W; Wang CH; Winchester DJ; Marsh R; Prinz RA; Baker MS
Surgery; 2016 Dec; 160(6):1466-1476. PubMed ID: 27614417
[TBL] [Abstract][Full Text] [Related]
7. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
[TBL] [Abstract][Full Text] [Related]
8. Resection status, age and nodal involvement determine survival among patients receiving adjuvant chemoradiotherapy in pancreatic adenocarcinoma.
Moghanaki D; Mick R; Furth EE; Sohal D; Salmon PM; Behbahani A; Morgans AK; Miller SM; Giantonio BJ; Whittington RW; Haller DG; Rosato EF; Plastaras JP
JOP; 2011 Sep; 12(5):438-44. PubMed ID: 21904068
[TBL] [Abstract][Full Text] [Related]
9. Has survival improved following resection for pancreatic adenocarcinoma?
Luberice K; Downs D; Sadowitz B; Ross S; Rosemurgy A
Am J Surg; 2017 Aug; 214(2):341-346. PubMed ID: 28601189
[TBL] [Abstract][Full Text] [Related]
10. Distal pancreatectomy for pancreatic carcinoma in the era of multimodal treatment.
Paye F; Micelli Lupinacci R; Bachellier P; Boher JM; Delpero JR;
Br J Surg; 2015 Feb; 102(3):229-36. PubMed ID: 25533421
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis.
de Geus SW; Eskander MF; Bliss LA; Kasumova GG; Ng SC; Callery MP; Tseng JF
Surgery; 2017 Mar; 161(3):592-601. PubMed ID: 28341441
[TBL] [Abstract][Full Text] [Related]
12. From street address to survival: Neighborhood socioeconomic status and pancreatic cancer outcomes.
Eskander MF; Hamad A; Li Y; Fisher JL; Oppong B; Obeng-Gyasi S; Tsung A
Surgery; 2022 Mar; 171(3):770-776. PubMed ID: 34876291
[TBL] [Abstract][Full Text] [Related]
13. The incidence and outcomes of pancreatectomy in patients with metastatic pancreatic adenocarcinoma.
McKenzie S; Mailey B; Artinyan A; Kim J; Ellenhorn JD
JOP; 2010 Jul; 11(4):341-7. PubMed ID: 20601808
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
[TBL] [Abstract][Full Text] [Related]
15. National patterns of care for pancreatic cancer. Results of a survey by the Commission on Cancer.
Janes RH; Niederhuber JE; Chmiel JS; Winchester DP; Ocwieja KC; Karnell JH; Clive RE; Menck HR
Ann Surg; 1996 Mar; 223(3):261-72. PubMed ID: 8604906
[TBL] [Abstract][Full Text] [Related]
16. Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective.
Nathan H; Wolfgang CL; Edil BH; Choti MA; Herman JM; Schulick RD; Cameron JL; Pawlik TM
J Surg Oncol; 2009 Feb; 99(2):87-92. PubMed ID: 19021191
[TBL] [Abstract][Full Text] [Related]
17. Underuse of surgical resection among elderly patients with early-stage pancreatic cancer.
He W; Zhao H; Chan W; Lopez D; Shroff RT; Giordano SH
Surgery; 2015 Nov; 158(5):1226-34. PubMed ID: 26138347
[TBL] [Abstract][Full Text] [Related]
18. Very Early Onset Pancreatic Adenocarcinoma - Clinical Presentation, Risk Factors and Therapeutic Options.
Bunduc Ș; Iacob R; Costache R; Stoica B; Radu C; Gheorghe C
Chirurgia (Bucur); 2018; 113(3):405-411. PubMed ID: 29981672
[No Abstract] [Full Text] [Related]
19. Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma.
Yang R; Cheung MC; Byrne MM; Jin X; Montero AJ; Jones C; Koniaris LG
Arch Surg; 2010 Jan; 145(1):49-56. PubMed ID: 20083754
[TBL] [Abstract][Full Text] [Related]
20. Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer.
Mirkin KA; Greenleaf EK; Hollenbeak CS; Wong J
Cancer; 2016 Oct; 122(19):2979-87. PubMed ID: 27328270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
